| n(%) |
---|---|
 | (N = 24) |
Gender | Â |
Male | 11 (46) |
Female | 13 (54) |
Age | Â |
Mean (SD) | 62 (8.8) |
Living Arrangements | Â |
Partner/spouse | 16 (67) |
Partner/spouse and children | 6 (25) |
Alone | 2 (8) |
Highest Level of Education | Â |
University degree or higher | 10 (42) |
Certificate or diploma | 8 (33) |
Secondary school | 5 (21) |
Primary school | 1 (4) |
Region | Â |
Metropolitan area | 11 (46) |
Regional/rural area | 13 (54) |
Treatment | Â |
Autologous Stem Cell Transplant | 16 (67) |
Chemotherapy | 6 (25) |
Radiotherapy | 5 (21) |
Other (e.g., steroids, Thalidomide/Revlimid) | 17 (71) |
Time Since Treatment Completion | Â |
2-4Â months ago | 4 (17) |
5-7Â months ago | 9 (37.5) |
8-10Â months | 2 (8) |
11-12Â months | 4 (17) |
Over 12Â months | 1 (4) |
Ongoing (e.g., thalidomide) | 4 (17) |